IRIS Accounts Production v24.1.0.578 07048873 director 5.4.23 31.3.24 31.3.24 0 0 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh070488732023-04-04070488732024-03-31070488732023-04-052024-03-31070488732022-03-31070488732022-04-012023-04-04070488732023-04-0407048873ns15:EnglandWales2023-04-052024-03-3107048873ns14:PoundSterling2023-04-052024-03-3107048873ns10:Director12023-04-052024-03-3107048873ns10:PrivateLimitedCompanyLtd2023-04-052024-03-3107048873ns10:SmallEntities2023-04-052024-03-3107048873ns10:AuditExemptWithAccountantsReport2023-04-052024-03-3107048873ns10:SmallCompaniesRegimeForDirectorsReport2023-04-052024-03-3107048873ns10:SmallCompaniesRegimeForAccounts2023-04-052024-03-3107048873ns10:FullAccounts2023-04-052024-03-3107048873ns10:CompanySecretary12023-04-052024-03-3107048873ns10:RegisteredOffice2023-04-052024-03-3107048873ns5:CurrentFinancialInstruments2024-03-3107048873ns5:CurrentFinancialInstruments2023-04-0407048873ns5:ShareCapital2024-03-3107048873ns5:ShareCapital2023-04-0407048873ns5:RevaluationReserve2024-03-3107048873ns5:RevaluationReserve2023-04-0407048873ns5:RetainedEarningsAccumulatedLosses2024-03-3107048873ns5:RetainedEarningsAccumulatedLosses2023-04-0407048873ns5:ComputerEquipment2023-04-052024-03-3107048873ns5:ComputerEquipment2023-04-0407048873ns5:ComputerEquipment2024-03-3107048873ns5:ComputerEquipment2023-04-0407048873ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-03-3107048873ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-04-0407048873ns5:CurrentFinancialInstruments2023-04-052024-03-3107048873ns5:DeferredTaxation2023-04-0407048873ns5:DeferredTaxation2023-04-052024-03-3107048873ns5:DeferredTaxation2024-03-3107048873ns5:RevaluationReserve2023-04-04
REGISTERED NUMBER: 07048873 (England and Wales)















DHARIWAL MEDICAL LIMITED

Unaudited Financial Statements

For The Period 5 April 2023 to 31 March 2024






DHARIWAL MEDICAL LIMITED (REGISTERED NUMBER: 07048873)






Contents of the Financial Statements
For The Period 5 April 2023 to 31 March 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4

Report of the Accountants 7

DHARIWAL MEDICAL LIMITED

Company Information
For The Period 5 April 2023 to 31 March 2024







DIRECTOR: Dr N K Dhariwal FRCA FFFARCSI





SECRETARY: A Dhariwal





REGISTERED OFFICE: 4 Graham Park Road
Gosforth
Newcastle
Tyne and Wear
NE3 4BH





REGISTERED NUMBER: 07048873 (England and Wales)





ACCOUNTANTS: Ron Joyce Ltd
Chartered Certified Accountant
18 Norham Road
Whitley Bay
Tyne and Wear
NE26 2SD

DHARIWAL MEDICAL LIMITED (REGISTERED NUMBER: 07048873)

Balance Sheet
31 March 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 1,411 1,882

CURRENT ASSETS
Debtors 5 3,683 5,613
Investments 6 1,067,667 869,713
Cash at bank 11,429 74,339
1,082,779 949,665
CREDITORS
Amounts falling due within one year 7 939 17,174
NET CURRENT ASSETS 1,081,840 932,491
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,083,251

934,373

PROVISIONS FOR LIABILITIES 9 268 358
NET ASSETS 1,082,983 934,015

CAPITAL AND RESERVES
Called up share capital 9 9
Revaluation reserve 10 194,045 (8,964 )
Retained earnings 888,929 942,970
SHAREHOLDERS' FUNDS 1,082,983 934,015

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

DHARIWAL MEDICAL LIMITED (REGISTERED NUMBER: 07048873)

Balance Sheet - continued
31 March 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 15 August 2024 and were signed by:





Dr N K Dhariwal FRCA FFFARCSI - Director


DHARIWAL MEDICAL LIMITED (REGISTERED NUMBER: 07048873)

Notes to the Financial Statements
For The Period 5 April 2023 to 31 March 2024

1. STATUTORY INFORMATION

Dhariwal Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Significant judgements
There were no judgements made that were significant enough to warrant disclosure.

Turnover
Turnover represents income for the sale of medical services provided and excludes VAT as the supply is exempt and the company is not VAT registered.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Computer equipment - 25% on reducing balance

Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Significant estimates
There were no estimates made that were significant enough to warrant disclosure.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was NIL (2023 - NIL).

DHARIWAL MEDICAL LIMITED (REGISTERED NUMBER: 07048873)

Notes to the Financial Statements - continued
For The Period 5 April 2023 to 31 March 2024

4. TANGIBLE FIXED ASSETS
Computer
equipment
£   
COST
At 5 April 2023
and 31 March 2024 5,356
DEPRECIATION
At 5 April 2023 3,474
Charge for period 471
At 31 March 2024 3,945
NET BOOK VALUE
At 31 March 2024 1,411
At 4 April 2023 1,882

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 3,683 5,613

6. CURRENT ASSET INVESTMENTS
2024 2023
£    £   
Listed investments 1,067,667 869,713

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Taxation and social security (8,221 ) 6,517
Other creditors 9,160 10,657
939 17,174

Included in other creditors are amounts owed to the Director, this year he was owed £3,542 (£2,923 - 2023).

8. FINANCIAL INSTRUMENTS

Debtors are shown at their impaired value (i.e. less doubtful debts).

9. PROVISIONS FOR LIABILITIES
2024 2023
£    £   
Deferred tax 268 358

DHARIWAL MEDICAL LIMITED (REGISTERED NUMBER: 07048873)

Notes to the Financial Statements - continued
For The Period 5 April 2023 to 31 March 2024

9. PROVISIONS FOR LIABILITIES - continued

Deferred
tax
£   
Balance at 5 April 2023 358
Provided during period (90 )
Balance at 31 March 2024 268

10. RESERVES
Revaluation
reserve
£   
At 5 April 2023 (8,964 )
Revaluation reserve movement 203,009

At 31 March 2024 194,045

11. RELATED PARTY DISCLOSURES

No transactions with related parties were undertaken that required disclosure under FRS 102 section 1A small entities.

DHARIWAL MEDICAL LIMITED

Report of the Accountants to the Director of
Dhariwal Medical Limited

The following reproduces the text of the report prepared for the director in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Director are not required to be filed with the Registrar of Companies.

As described on the Balance Sheet you are responsible for the preparation of the financial statements for the period ended 31 March 2024 set out on pages three to eleven and you consider that the company is exempt from an audit.

In accordance with your instructions, we have compiled these unaudited financial statements in order to assist you to fulfil your statutory responsibilities, from the accounting records and information and explanations supplied to us.






Ron Joyce Ltd
Chartered Certified Accountant
18 Norham Road
Whitley Bay
Tyne and Wear
NE26 2SD


16 August 2024